|
|
|
|
LEADER |
06987nma a2202209 u 4500 |
001 |
EB002048472 |
003 |
EBX01000000000000001192138 |
005 |
00000000000000.0 |
007 |
cr||||||||||||||||||||| |
008 |
220822 ||| eng |
020 |
|
|
|a books978-3-0365-2652-2
|
020 |
|
|
|a 9783036526539
|
020 |
|
|
|a 9783036526522
|
100 |
1 |
|
|a Ptito, Maurice
|
245 |
0 |
0 |
|a The Retina in Health and Disease
|h Elektronische Ressource
|
260 |
|
|
|a Basel, Switzerland
|b MDPI - Multidisciplinary Digital Publishing Institute
|c 2021
|
300 |
|
|
|a 1 electronic resource (465 p.)
|
653 |
|
|
|a monkeys
|
653 |
|
|
|a microglia
|
653 |
|
|
|a exendin-4
|
653 |
|
|
|a trichostatin A (TSA)
|
653 |
|
|
|a photoreceptor
|
653 |
|
|
|a retinal microglia
|
653 |
|
|
|a senescence-associated galactosidase activity
|
653 |
|
|
|a programmed cell death
|
653 |
|
|
|a hypoxia
|
653 |
|
|
|a dLGN
|
653 |
|
|
|a vascularization
|
653 |
|
|
|a optic neuritis
|
653 |
|
|
|a cognitive decline
|
653 |
|
|
|a microvascular complications and dysfunction
|
653 |
|
|
|a outer segments
|
653 |
|
|
|a natural bioactive extracts
|
653 |
|
|
|a antioxidants
|
653 |
|
|
|a astrocytes
|
653 |
|
|
|a respiration
|
653 |
|
|
|a precocial bird species
|
653 |
|
|
|a light damage
|
653 |
|
|
|a histone deacetylase
|
653 |
|
|
|a retinal detachment
|
653 |
|
|
|a mitochondria
|
653 |
|
|
|a retinal ganglion cells
|
653 |
|
|
|a neuroprotection
|
653 |
|
|
|a clinical trials
|
653 |
|
|
|a zebrafish
|
653 |
|
|
|a neurodegeneration
|
653 |
|
|
|a systemic disease
|
653 |
|
|
|a bioenergetics
|
653 |
|
|
|a photoreceptors
|
653 |
|
|
|a neurod
|
653 |
|
|
|a functional analysis
|
653 |
|
|
|a retinopathy
|
653 |
|
|
|a ultrathin parylene
|
653 |
|
|
|a eye inflammation
|
653 |
|
|
|a gut microbiome
|
653 |
|
|
|a amyloid
|
653 |
|
|
|a retinal glial cell
|
653 |
|
|
|a diabetes mellitus
|
653 |
|
|
|a diabetic retinopathy
|
653 |
|
|
|a osteopontin
|
653 |
|
|
|a iPSC
|
653 |
|
|
|a neurovascular unit
|
653 |
|
|
|a reactive oxygen species
|
653 |
|
|
|a ATP
|
653 |
|
|
|a electron microscopy
|
653 |
|
|
|a FPR receptor
|
653 |
|
|
|a age-related macular degeneration
|
653 |
|
|
|a HCAR1
|
653 |
|
|
|a signal transducer and activator of transcription 3
|
653 |
|
|
|a retinal fluorescence imaging
|
653 |
|
|
|a biomarker
|
653 |
|
|
|a altricial bird species
|
653 |
|
|
|a eye
|
653 |
|
|
|a vascular endothelial growth factor (VEGF)
|
653 |
|
|
|a diabetes
|
653 |
|
|
|a Prox1
|
653 |
|
|
|a GPR81
|
653 |
|
|
|a ON/OFF asymmetry
|
653 |
|
|
|a hyperglycemia
|
653 |
|
|
|a macroglia
|
653 |
|
|
|a retinogenesis
|
653 |
|
|
|a gut-retina axis
|
653 |
|
|
|a autophagy
|
653 |
|
|
|a Neurosciences / bicssc
|
653 |
|
|
|a 3,5-DHBA
|
653 |
|
|
|a growth cone
|
653 |
|
|
|a optical coherence tomography
|
653 |
|
|
|a resting state
|
653 |
|
|
|a metabolism
|
653 |
|
|
|a axon
|
653 |
|
|
|a GRP78
|
653 |
|
|
|a microglia morphotype
|
653 |
|
|
|a AII amacrine cell
|
653 |
|
|
|a parvalbumin
|
653 |
|
|
|a Medicine and Nursing / bicssc
|
653 |
|
|
|a immunohistochemistry
|
653 |
|
|
|a retinal inflammation
|
653 |
|
|
|a LED screen
|
653 |
|
|
|a AMD
|
653 |
|
|
|a motor protein
|
653 |
|
|
|a development
|
653 |
|
|
|a retina
|
653 |
|
|
|a endoplasmic reticulum
|
653 |
|
|
|a glucagon-like peptide-1
|
653 |
|
|
|a lipopolysaccharide
|
653 |
|
|
|a angiogenesis
|
653 |
|
|
|a regeneration
|
653 |
|
|
|a epidermal growth factor
|
653 |
|
|
|a inflammation
|
653 |
|
|
|a spinal cord injury
|
653 |
|
|
|a visual system
|
653 |
|
|
|a complication
|
653 |
|
|
|a gap junction
|
653 |
|
|
|a n/a
|
653 |
|
|
|a Notch
|
653 |
|
|
|a stem cell therapy
|
653 |
|
|
|a mesenchymal stem cells
|
653 |
|
|
|a electroretinography
|
653 |
|
|
|a progenitor cell
|
653 |
|
|
|a visual function
|
653 |
|
|
|a lactate
|
653 |
|
|
|a complement cascade
|
653 |
|
|
|a multiple sclerosis
|
653 |
|
|
|a African-American
|
653 |
|
|
|a atypical cannabinoid receptors
|
653 |
|
|
|a retinal pigment epithelium
|
653 |
|
|
|a Ac2-26
|
653 |
|
|
|a CD4+CD25+
|
653 |
|
|
|a germ-free mice
|
653 |
|
|
|a catalase
|
653 |
|
|
|a retinal protection
|
653 |
|
|
|a experimental models
|
653 |
|
|
|a retinal vessels
|
653 |
|
|
|a high-fat diet
|
653 |
|
|
|a Müller cells
|
653 |
|
|
|a iPSC-RPE
|
653 |
|
|
|a GFAP
|
653 |
|
|
|a angiography
|
653 |
|
|
|a remodeling
|
653 |
|
|
|a apoptosis
|
653 |
|
|
|a fingolimod
|
653 |
|
|
|a myosin 1C
|
653 |
|
|
|a betulinic acid
|
653 |
|
|
|a kallikrein-kinin system
|
653 |
|
|
|a optical filter
|
653 |
|
|
|a black
|
653 |
|
|
|a EEG
|
653 |
|
|
|a rhodopsin
|
653 |
|
|
|a early detection
|
653 |
|
|
|a stress response
|
653 |
|
|
|a retinal transplantation
|
653 |
|
|
|a retinal degenerative diseases
|
653 |
|
|
|a typical cannabinoid receptors
|
653 |
|
|
|a eccentricity
|
653 |
|
|
|a visual hallucination
|
653 |
|
|
|a RNA sequencing
|
653 |
|
|
|a HDAC
|
653 |
|
|
|a oxidative stress
|
653 |
|
|
|a unfolded protein response
|
653 |
|
|
|a retinal light injury
|
653 |
|
|
|a retinal degeneration
|
653 |
|
|
|a Alzheimer's disease
|
653 |
|
|
|a Charles Bonnet syndrome
|
653 |
|
|
|a microvascular
|
653 |
|
|
|a Drp1
|
653 |
|
|
|a immunodeficient RCS rat
|
653 |
|
|
|a optic nerve crush
|
653 |
|
|
|a arterioles
|
653 |
|
|
|a inflammatory mediators
|
653 |
|
|
|a kinin receptors
|
653 |
|
|
|a cellular senescence
|
653 |
|
|
|a ischemia-reperfusion injury
|
700 |
1 |
|
|a Bouskila, Joseph
|
700 |
1 |
|
|a Ptito, Maurice
|
700 |
1 |
|
|a Bouskila, Joseph
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b DOAB
|a Directory of Open Access Books
|
500 |
|
|
|a Creative Commons (cc), https://creativecommons.org/licenses/by/4.0/
|
028 |
5 |
0 |
|a 10.3390/books978-3-0365-2652-2
|
856 |
4 |
0 |
|u https://www.mdpi.com/books/pdfview/book/4745
|7 0
|x Verlag
|3 Volltext
|
856 |
4 |
2 |
|u https://directory.doabooks.org/handle/20.500.12854/77126
|z DOAB: description of the publication
|
082 |
0 |
|
|a 540
|
082 |
0 |
|
|a 610
|
082 |
0 |
|
|a 333
|
082 |
0 |
|
|a 580
|
082 |
0 |
|
|a 700
|
520 |
|
|
|a Vision is the most important sense in higher mammals. The retina is the first step in visual processing and the window to the brain. It is not surprising that problems arising in the retina lead to moderate to severe visual impairments. We offer here a collection of reviews as well as original papers dealing with various aspects of retinal function as well as dysfunction. New approaches in retinal research are described, such as the expression and localization of the endocannabinoid system in the normal retina and the role of cannabinoid receptors that could offer new avenues of research in the development of potential treatments for retinal diseases. Moreover, new insights are offered in advancing knowledge towards the prevention and cure of visual pathologies, mainly AMD, RP, and diabetic retinopathy.
|